Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

Revenues for LALPATHLAB are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 3.50800
forwardPE 42.06838
debtToEquity 6.44100
earningsGrowth 0.16300
revenueGrowth 0.10700
grossMargins 0.58257
operatingMargins 0.25130
trailingEps 63.92000
forwardEps 29.38000

LALPATHLAB's current ratio being 3.508 suggests the company will have no issues paying off its short-term debt. With sufficient cash reserves and current assets, LALPATHLAB can easily cover its immediate liabilities, reflecting solid financial health.
LALPATHLAB's positive earnings and revenue growth indicate that the company is well-positioned for business expansion. This growth suggests a strong financial trajectory, with LALPATHLAB expected to continue increasing its profits and revenue in the coming periods.
Positive gross and operating margins for LALPATHLAB suggest that the company is operating profitably. These margins highlight LALPATHLAB's efficiency in managing costs while maintaining healthy revenue streams, contributing to its overall financial strength.
LALPATHLAB's forward EPS being lower than its trailing EPS suggests the company is expected to face declining profits. This points to a less favorable financial outlook for the coming year.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

The steady upward revision of LALPATHLAB's price projections indicates growing confidence in the company's performance. Analysts are becoming increasingly optimistic about LALPATHLAB's future prospects and potential for growth.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


Recent trading of LALPATHLAB stock saw 48 sales, with market price at 3036.894785563151 per share.LALPATHLAB saw 1 buy transactions, with market price of 3308.5.Increased sells at Dr. Lal PathLabs Limited's current price levels point to a possible decline. If this trend of selling continues, it may signal that the stock's price will face further downward pressure, reflecting investor concerns.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts are favoring LALPATHLAB with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider LALPATHLAB as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.